Mixed Salts Of A Single-entity Amphetamine Product Capsule, Extended Release
Product Images NDC 0406-0805

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mixed Salts Of A Single-entity Amphetamine Product (NDC 0406-0805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Mixed Salts Of A Single Entity Amphetamine Product 1)

A line graph depicting mean concentration (ng/mL) of d-Amphetamine and l-Amphetamine in plasma over time (hours) up to 60 hours. It compares Mixed Salts of a Single-Entity Amphetamine Product Extended-Release Capsules 37.5 mg with MAS-ER 25 mg plus MAS-IR 12.5 mg formulations, showing concentration curves for both d- and l- amphetamine isomers.*

FDA Label Image

Figure 2 (Mixed Salts Of A Single Entity Amphetamine Product 2)

A line graph comparing the LS Mean (SE) PERMP Total Scores over time post-dose (hours) between placebo and Mixed Salts of a Single-Entity Amphetamine Product extended-release capsules. The graph shows time on the x-axis from -0.5 to 16 hours and scores on the y-axis from 170 to 330, with data points and error bars for each time interval.*

FDA Label Image

Principal Display Panel (12.5 mg Capsule Bottle Label)

Label for Mixed Salts of a Single-Entity Amphetamine Product Extended-Release Capsules 12.5 mg by SpecGx LLC. The label shows a carton containing 100 capsules, dosing as once daily, prescription only. It lists active ingredients Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. The label includes storage instructions, cautions, and an image of a marked beige capsule.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Label of Mallinckrodt Mixed Salts of a Single-Entity Amphetamine Product Extended-Release Capsules, 25 mg strength. The label shows the NDC 0406-0803-01, package contains 100 capsules, and specifies once-daily oral dosing. It includes a dosage capsule image marked with 'M' and '25 mg'. Labeler is SpecGx LLC, manufacturing location Webster Groves, MO.*

FDA Label Image

Principal Display Panel (37.5 mg Capsule Bottle Label)

Label for Mixed Salts of a Single-Entity Amphetamine Product extended-release capsules, 37.5 mg strength. The label shows a pink and blue capsule image marked with 37.5 mg, the NDC number 0406-0807-01, a 100-capsule count, and instructions for once-daily oral use. It includes storage information, pharmacist dispensing guidance, and the manufacturer SpecGx LLC in Webster Groves, MO.*

FDA Label Image

Principal Display Panel (25 mg Capsule Bottle Label)

Label of Mixed Salts of a Single-Entity Amphetamine Product extended-release capsules showing 50 mg strength. The label lists active ingredients including dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. It indicates once-daily oral dosing, 100 capsules per container, and is labeled for prescription use only by SpecGx LLC. The capsule image is blue and imprinted with "M 50 mg."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.